Literature DB >> 12752141

Expression of cyclooxygenase type 2 in lepromatous and tuberculoid leprosy lesions.

A E C Kiszewski1, E Becerril, J Baquera, R Ruiz-Maldonado, R Hernández Pando.   

Abstract

BACKGROUND: Leprosy is an infectious disease with two polar forms, tuberculoid leprosy (TL) and lepromatous leprosy (LL), which are dominated by T-helper (Th) 1 and Th2 cells, respectively. High concentrations of prostaglandin E2 produced by the inducible enzyme cyclooxygenase type 2 (COX-2) in LL could inhibit Th1 cytokine production, contributing to T-cell anergy.
OBJECTIVES: To compare the COX-2 expression in LL and TL.
METHODS: Skin biopsies from 40 leprosy patients (LL, n = 20; TL, n = 20) were used to determine by immunohistochemistry and automated morphometry the percentage of COX-2 immunostained cells.
RESULTS: Most COX-2-positive cells were macrophages; their percentages in the inflammatory infiltrate located in the papillary dermis, reticular dermis and periadnexally were significantly higher in LL than TL (P < 0.001 by Student's t-test).
CONCLUSIONS: The high expression of COX-2 in LL may be related to high prostaglandin production contributing to T-cell anergy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752141     DOI: 10.1046/j.1365-2133.2003.05179.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy.

Authors:  Mayra Silva Miranda; Kendy Wek Rodríguez; Erasmo Martínez Cordero; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

Authors:  J de Souza Sales; F A Lara; T P Amadeu; T de Oliveira Fulco; J A da Costa Nery; E P Sampaio; R O Pinheiro; E N Sarno
Journal:  Clin Exp Immunol       Date:  2011-05-18       Impact factor: 4.330

Review 3.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

Review 4.  New insights into the pathogenesis of leprosy: contribution of subversion of host cell metabolism to bacterial persistence, disease progression, and transmission.

Authors:  Geraldo Moura Pereira; Maria Cristina Vidal Pessolani; Cristiana Santos de Macedo; Flavio Alves Lara; Roberta Olmo Pinheiro; Veronica Schmitz; Marcia de Berrêdo-Pinho
Journal:  F1000Res       Date:  2020-01-31

5.  Metabonomics reveals drastic changes in anti-inflammatory/pro-resolving polyunsaturated fatty acids-derived lipid mediators in leprosy disease.

Authors:  Julio J Amaral; Luis Caetano M Antunes; Cristiana S de Macedo; Katherine A Mattos; Jun Han; Jingxi Pan; André L P Candéa; Maria das Graças M O Henriques; Marcelo Ribeiro-Alves; Christoph H Borchers; Euzenir N Sarno; Patrícia T Bozza; B Brett Finlay; Maria Cristina V Pessolani
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.